Go to content
UR Home

Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial

Hart, C. ; Vogelhuber, M. ; Hafner, C. ; Landthaler, M. ; Berneburg, M. ; Haferkamp, S. ; Herr, W. ; Reichle, A.



Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons